# Combined CABG and Stem-Cell Transplantation for Heart Failure

> **NCT00418418** · PHASE2 · UNKNOWN · sponsor: **University of Helsinki** · enrollment: 60 (estimated)

## Conditions studied

- Heart Failure
- Myocardial Infarction
- Coronary Artery Disease

## Interventions

- **PROCEDURE:** Coronary bypass operation
- **PROCEDURE:** Bone marrow aspiration (crista iliaca)
- **BIOLOGICAL:** Intramyocardial mesenchymal stem cell transplantation
- **BIOLOGICAL:** Intramyocardial injection of autologous serum

## Key facts

- **NCT ID:** NCT00418418
- **Lead sponsor:** University of Helsinki
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-10
- **Primary completion:** 2009-12
- **Final completion:** 2010-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2008-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00418418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00418418, "Combined CABG and Stem-Cell Transplantation for Heart Failure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00418418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*